Valid Insight (@ValidInsight) header
Valid Insight (@ValidInsight) profile picture

Award winning global market access consultancy delivering real knowledge, valid perspectives and trusted evidence: https://teapawt.net/t.co/zK6m3WYF8n

London, England
Joined January 2016
Photo by Valid Insight (@ValidInsight)Photo by Valid Insight (@ValidInsight)Photo by Valid Insight (@ValidInsight)Photo by Valid Insight (@ValidInsight)Photo by Valid Insight (@ValidInsight)Photo by Valid Insight (@ValidInsight)Photo by Valid Insight (@ValidInsight)Photo by Valid Insight (@ValidInsight)Photo by Valid Insight (@ValidInsight)Photo by Valid Insight (@ValidInsight)
⏰ Starting in 30 minutes - "Using a digital pricing and market access simulator App to enhance product development". Don't miss out on @ValidInsight roundtable presentation at 4:40 PM 🖥️ buff.ly/361e7Pd #PPMAConf
⏰ 20 minutes to go! - "Roundtables - Perspectives on remote project delivery for global pricing and market access functions: operational aspects and life hacks that ensure market access continuity". Join @ValidInsight presentation at 11 AM. 🖥️ buff.ly/361e7Pd #PPMAConf
Cancer drug could be repurposed to provide treatment for brain aneurysms goo.gl/fb/c39NzP
Valid Insight retweeted
£3.3m boost for mental illness in children pharmatimes.com/news/3.3m_bo… #news #lifesciences
2
2
"Vaccines save us from diseases, then cause us to forget the diseases from which they save us" on.natgeo.com/2NfESpF
23
1,190
63
2,758
Current reimbursement pathways can be unsupportive of #innovative #MedTech solutions. @ValueConnected & @medtecheurope have partnered to ensure Value Based Access Programs (#VBAP) align providers, payers, manufacturers & patients in #VBHC. More here: bit.ly/2KW7zW4
2
4
Valid Insight retweeted
There are about 30,000 cases of XDR strain TB in over 100 countries. It is estimated that three-quarters of those patients die before diagnosis and for those who receive treatment, the cure rate is only 34%. Read the excellent news for patients here: nytimes.com/2019/08/14/healt…
1
2
Valid Insight retweeted
As the buzz around #voiceassistants increases, pharma innovators are asking how they can leverage this technology with #HCPs, #payers & patients. Read more in our latest blog post ow.ly/cBm550vwvfX
2
1
What are you hoping to gain from attending ISPOR this year? #ISPOR #ISPOREurope #marketaccess
1
1
The benefits of patient-centric approaches within market access >> ow.ly/a4xK50vBSQb The first in a 2-part series #PatientEngagement #HEOR
2
1
Valid Insight retweeted
Do you know that there is a dedicated #Reimbursement international annual assembly of #MedTech industry leaders, #payers, #healthauthorities, and #patientassociations gathering together to discuss and explore ways of making better healthcare products accessible globally?
1
1
1
Valid Insight retweeted
On the episode, we bring back our favorite Canadian pharmacist, Brandie Mabee. We talk about the new proposals about the US importing drugs from Canada and it’s impact on drug pricing and it’s feasibility of implementation. Listen here: rxradio.fm/pages/listen #Pharmacy
1
1
1
2
Understanding the evidence behind the soaring costs of drugs is crucial to fixing the #drugpricing system. Here are the three issues that must be addressed in comprehensive legislation: arnoldventures.org/stories/k…
2
12
1
18
According to our #survey, just over a quarter of #freelancers (n=11/39; 28.2%) supporting clients with #marketaccess and related projects never actively pursue business with new clients
1
1
2
Valid Insight retweeted
#FDA shatters #generics drug approval record - has approved or tentatively approved 1,028 generic drugs since the end of July, already surpasses 971 approvals for 2018 federal fiscal year | #pharma ow.ly/3baJ30pmAkx
1
1
Valid Insight retweeted
Widespread data inaccuracies can affect claims management,referrals, credentialing, and more. Read how a health IT company is helping #payers improve their data to avoid needless costs. medcitynews.com/2019/08/how-…
2
1